Skip to main content
. 2019 Apr 7;46(1):154–162. doi: 10.1093/schbul/sbz025

Table 1.

Demographic and Clinical Information

HC BD SZ SZ-A F or χ2 (P)
N 73 59 88 76
Age 37.2 (11.3) 38.4 (10.8) 35.6 (10.7) 36.6 (10.9) 0.8 (.47)
% Male 54.8 35.6 62.5 53.9 10.5 (.02)
% per Site (1/2/3/4/5) 29/14/16/27/14 8/24/32/7/29 28/17/13/18/24 32/11/24/11/24 34.4 (<.01)
Education level (y) 14.8 (2.3) 14.7 (2.6) 12.8 (2.1) 13.6 (2.5) 12.0 (<.01)
Parental education level (y) 13.9 (2.7) 14.3 (2.5) 13.4 (3.3) 14.2 (2.7) 1.5 (.22)
SBS total 1.5 (0.9) 7.7 (1.2) 4.7 (1.3) 497.3 (<.01)
BDRS total 5.5 (5.3) 4.3 (4.6) 7.0 (6.5) 5.0 (.01)
Mood lability score 0.5 (0.1) 0.2 (0.1) 0.4 (0.1) 3.8 (.02)
YMRS total 10.0 (7.7) 9.9 (6.2) 13.1 (7.4) 5.1 (<.01)
BPRS total 40.2 (8.8) 43.2 (12.4) 49.7 (14.6) 10.8 (<.01)
CAINS anhedonia 8.4 (5.6) 12.3 (6.9) 14.4 (7.1) 7.8 (<.01)
CAINS blunting 0.8 (1.7) 3.8 (3.0) 3.3 (3.1) 22.0 (<.01)
UPSA-B total 83.9 (11.3) 84.6 (9.0) 75.0 (13.8) 77.8 (13.0) 10.7 (<.01)
Financial skills 43.7 (6.1) 42.9 (5.5) 39.1 (8.1) 40.9 (8.2) 6.2 (<.01)
Communication skills 40.3 (7.4) 41.5 (6.4) 35.8 (8.3) 37.0 (8.0) 8.7 (<.01)
% Taking antipsychotic 49.2 76.1 71.1 110.5 (<.01)
Antipsychotic dose (mg CPZ equivalent) 391.6 (522.7) 371.9 (301.0) 577.4 (778.2) 2.03 (.14)
% Taking mood stabilizer 69.5 13.6 28.9 92.5 (<.01)
% Taking antidepressant 59.3 26.1 56.6 74.0 (<.01)
% Taking anxiolytic 20.3 17.0 19.7 16.4 (<.01)

Note: BD, bipolar disorder; BDRS, Bipolar Depression Rating Scale; BPRS, Brief Psychiatric Rating Scale; CAINS, Clinical Assessment Interview for Negative Symptoms; CPZ, chlorpromazine; HC, healthy control; SBS, Schizo-Bipolar Scale; SZ, schizophrenia; SZ-A, schizoaffective disorder; UPSA-B, University of California San Diego Performance-Based Skills Assessment; YMRS, Young Mania Rating Scale. Numbers in parentheses represent the standard error.